SCHEMBL716424

SCHEMBL716424

NC(Cc1c[nH]cn1)C(=O)N(CC(=O)O)C(=O)C1CCC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15061108 0.77 TRHR (0.33)
SCHEMBL259180 0.76
SCHEMBL11041940 0.74 TRHR (0.32)
SCHEMBL9748876 0.73 GSR (0.37)
SCHEMBL8781640 0.73 TRHR (0.36)
Histidine SCHEMBL7609568 0.73 TRHR (0.33)
SCHEMBL30121454 0.72 NLN (0.33)
Histidine SCHEMBL6903283 0.71 TRHR (0.34)
SCHEMBL6026780 0.70 TRHR (0.46)
SCHEMBL6026783 0.70 TRHR (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240075043-A1 IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS Red Mountain Med Spa, LLC (US) 2024-03-07 US claimed
US-20220249505-A1 APPETITE SUPPRESSANT COMPOSITIONS AND METHODS THEREOF RED MOUNTAIN HOLDINGS, LLC (US) 2022-08-11 US claimed
US-20210275536-A1 APPETITE SUPPRESSANT COMPOSITIONS AND METHODS THEREOF RED MOUNTAIN HOLDINGS, LLC (US) 2021-09-09 US claimed
WO-2009049105-A2 METHODS FOR INDUCING SATIATION GELESIS, INC. (US) 2009-04-16 WO claimed
US-20250249018-A1 IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS INCLUDING BUPROPION FOR WEIGHT LOSS Red Mountain Med Spa, LLC (US) 2025-08-07 US disclosed
US-20250249017-A1 IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS INCLUDING NALTREXONE FOR WEIGHT LOSS Red Mountain Med Spa, LLC (US) 2025-08-07 US disclosed
US-20250249016-A1 IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS Red Mountain Med Spa, LLC (US) 2025-08-07 US disclosed
US-12303514-B2 Immediate and controlled release appetite suppressant compositions for weight loss Red Mountain Med Spa, LLC (US) 2025-05-20 US disclosed
US-20240075043-A1 IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS Red Mountain Med Spa, LLC (US) 2024-03-07 US disclosed
US-11896598-B2 Appetite suppressant compositions and methods thereof Red Mountain Med Spa, LLC (US) 2024-02-13 US disclosed
US-20230320384-A1 Methods and Compositions for Weight Management and for Improving Glycemic Control GELESIS LLC (US) 2023-10-12 US disclosed
US-11608339-B2 5-HT2C receptor agonists and compositions and methods of use ARENA PHARMACEUTICALS, INC. (US) 2023-03-21 US disclosed
WO-2017023679-A1 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE ARENA PHARMACEUTICALS, INC. (US) 2017-02-09 WO disclosed
WO-2017015095-A1 INHIBITING CTRP5 ACTION TO IMPROVE INSULIN RESISTANCE ASSOCIATED WITH OBESITY AND TYPE 2 DIABETES THE JOHNS HOPKINS UNIVERSITY (US) 2017-01-26 WO disclosed
WO-2016176177-A1 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE ARENA PHARMACEUTICALS, INC. (US) 2016-11-03 WO disclosed
WO-2015066344-A1 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE ARENA PHARMACEUTICALS, INC. (US) 2015-05-07 WO disclosed
US-20120052151-A1 METHODS AND COMPOSITIONS FOR WEIGHT MANAGEMENT AND FOR IMPROVING GLYCEMIC CONTROL GELESIS, LLC 2012-03-01 US disclosed
EP-2358218-A1 METHODS AND COMPOSITIONS FOR WEIGHT MANAGEMENT AND FOR IMPROVING GLYCEMIC CONTROL One S.R.L. (IT) 2011-08-24 EP disclosed
WO-2010059725-A1 METHODS AND COMPOSITIONS FOR WEIGHT MANAGEMENT AND FOR IMPROVING GLYCEMIC CONTROL ONE S.R.I. (IT) 2010-05-27 WO disclosed
WO-2009049105-A2 METHODS FOR INDUCING SATIATION GELESIS, INC. (US) 2009-04-16 WO disclosed